Save 50% on a 3-month Digiday+ membership. Ends Dec 5.
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
The case for and against AI-driven SEO in the zero-click era
As generative AI reshapes search, marketers debate the value of committing (or overcommitting) to an AI SEO strategy.
Hiring program in energy tech sector enlists military veterans to fill data center skills gap
Data center demand is projected to grow 33% annually by 2030, while the industry struggles to find qualified candidates for increasingly complex systems.
‘Regulate us like alcohol, don’t ban us’: Proposed hemp THC ban threatens to shut down countless brands
The proposed ban on THC-infused products was included in the bill Congress passed to end the government shutdown.